Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer
about
Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial.Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia.Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients.Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management.Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study.Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes.Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer
P2860
Q33432931-65417CBC-FCE4-47BA-9DC4-6585E04E9947Q33434223-A8C07B66-AB88-4058-A192-2B11FCF0EAB0Q35044368-283C7A1D-6C3C-4C6C-A0B4-534D074EFEEEQ35176826-A1E411D9-B539-4EDB-930A-B8041809A956Q36053032-EF8E0775-42D2-4598-992C-488000576F8FQ36242803-A8619BD2-157F-4447-BB68-2B2EB9EE86ACQ38447887-456B005E-6F95-471C-A108-4D039EF5C570Q40831081-CEAF8BCB-EF70-46CD-989F-692C3F5C6964Q54231437-07C2DAEF-78DD-4DFF-A6E8-B2162BD9C566Q59129830-E063E208-7CCB-4BB0-93E7-393F5E99A296
P2860
Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@ast
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@en
type
label
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@ast
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@en
prefLabel
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@ast
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@en
P2093
P2860
P50
P1433
P1476
Effect of chemotherapy delays ...... t of epithelial ovarian cancer
@en
P2093
D M O'Malley
E L Eisenhauer
J M Fowler
L J Copeland
P2860
P304
P356
10.1016/J.YGYNO.2011.10.003
P407
P577
2011-11-04T00:00:00Z